New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020
dc.contributor.author | Brenner, MJ | |
dc.contributor.author | Shenson, JA | |
dc.contributor.author | Rose, AS | |
dc.contributor.author | Valdez, TA | |
dc.contributor.author | Takashima, M | |
dc.contributor.author | Ahmed, OG | |
dc.contributor.author | Weissbrod, PA | |
dc.contributor.author | Hong, RS | |
dc.contributor.author | Djalilian, H | |
dc.contributor.author | Wolf, JS | |
dc.contributor.author | Morrison, RJ | |
dc.contributor.author | Santa Maria, PL | |
dc.contributor.author | Erbele, ID | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-01-09T17:27:13Z | |
dc.date.available | 2024-01-09T17:27:13Z | |
dc.date.issued | 2021-01-01 | |
dc.identifier.issn | 2473-974X | |
dc.identifier.issn | 2473-974X | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/34790883 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/191977 | en |
dc.description.abstract | Objectives: To evaluate new drugs and devices relevant to otolaryngology–head and neck surgery that were approved by the US Food and Drug Administration (FDA) in 2020. Data Sources: Publicly available device and therapeutic approvals from ENT (ear, nose, and throat), anesthesia, neurology (neurosurgery), and plastic and general surgery FDA committees. Review Methods: Members of the American Academy of Otolaryngology–Head and Neck Surgery’s Medical Devices and Drugs Committee reviewed new therapeutics and medical devices from a query of the FDA’s device and therapeutic approvals. Two independent reviewers assessed the drug’s or device’s relevance to otolaryngology, classified to subspecialty field, with a critical review of available scientific literature. Conclusions: The Medical Devices and Drugs Committee reviewed 53 new therapeutics and 1094 devices (89 ENT, 140 anesthesia, 511 plastic and general surgery, and 354 neurology) approved in 2020. Ten drugs and 17 devices were considered relevant to the otolaryngology community. Rhinology saw significant improvements around image guidance systems; indications for cochlear implantation expanded; several new monoclonal therapeutics were added to head and neck oncology’s armamentarium; and several new approvals appeared for facial plastics surgery, pediatric otolaryngology, and comprehensive otolaryngology. Implications for Practice: New technologies and pharmaceuticals offer the promise of improving how we care for otolaryngology patients. However, judicious introduction of innovations into practice requires a nuanced understanding of safety, advantages, and limitations. Working knowledge of new drugs and medical devices approved for the market helps clinicians tailor patient care accordingly. | |
dc.format.medium | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.rights | Licence for published version: Creative Commons Attribution-NonCommercial 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | FDA | |
dc.subject | drug | |
dc.subject | medical device | |
dc.subject | therapeutic | |
dc.title | New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020 | |
dc.type | Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/191977/2/New Medical Device and Therapeutic Approvals in Otolaryngology State of the Art Review 2020.pdf | |
dc.identifier.doi | 10.1177/2473974X211057035 | |
dc.identifier.doi | https://dx.doi.org/10.7302/21978 | |
dc.identifier.source | OTO Open | |
dc.description.version | Published version | |
dc.date.updated | 2024-01-09T17:27:10Z | |
dc.identifier.orcid | 0000-0003-4926-0957 | |
dc.identifier.orcid | 0000-0001-7751-7508 | |
dc.identifier.orcid | 0000-0003-3753-2329 | |
dc.identifier.orcid | 0000-0002-8520-7910 | |
dc.identifier.orcid | 0000-0001-9790-3529 | |
dc.identifier.orcid | 0000-0001-7977-6925 | |
dc.identifier.orcid | 0000-0001-5905-0270 | |
dc.identifier.orcid | 0000-0003-3216-9620 | |
dc.identifier.orcid | 0000-0002-2313-8542 | |
dc.identifier.orcid | 0000-0002-3428-3497 | |
dc.description.filedescription | Description of New Medical Device and Therapeutic Approvals in Otolaryngology State of the Art Review 2020.pdf : Published version | |
dc.identifier.volume | 5 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 2473974X211057035 | |
dc.identifier.name-orcid | Brenner, MJ; 0000-0003-4926-0957 | |
dc.identifier.name-orcid | Shenson, JA; 0000-0001-7751-7508 | |
dc.identifier.name-orcid | Rose, AS; 0000-0003-3753-2329 | |
dc.identifier.name-orcid | Valdez, TA; 0000-0002-8520-7910 | |
dc.identifier.name-orcid | Takashima, M; 0000-0001-9790-3529 | |
dc.identifier.name-orcid | Ahmed, OG | |
dc.identifier.name-orcid | Weissbrod, PA; 0000-0001-7977-6925 | |
dc.identifier.name-orcid | Hong, RS | |
dc.identifier.name-orcid | Djalilian, H; 0000-0001-5905-0270 | |
dc.identifier.name-orcid | Wolf, JS; 0000-0003-3216-9620 | |
dc.identifier.name-orcid | Morrison, RJ; 0000-0002-2313-8542 | |
dc.identifier.name-orcid | Santa Maria, PL; 0000-0002-3428-3497 | |
dc.identifier.name-orcid | Erbele, ID | |
dc.working.doi | 10.7302/21978 | en |
dc.owningcollname | Otolaryngology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.